Join the Alemtuzumab group to help and get support from people like you.
Alemtuzumab News
FDA Medwatch Alert: FDA Warns About Rare But Serious Risks of Stroke and Blood Vessel Wall Tears with Multiple Sclerosis Drug Lemtrada (alemtuzumab)
The U.S. Food and Drug Administration (FDA) is warning that rare but serious cases of stroke and tears in the lining of arteries in the head and neck have occurred in patients with multiple sclerosis...
Further information
Related condition support groups
Chronic Lymphocytic Leukemia (CLL), Multiple Sclerosis, Rheumatoid Arthritis